By Gina Shaw
The idea of using autologous hematopoietic stem cell transplantation (AHSCT) to treat multiple sclerosis (MS) has been around for decades, but it’s garnered increased attention in recent weeks, thanks to a BBC feature program about research ongoing at the Sheffield Teaching Hospitals in the United Kingdom, which aired Jan. 18.
Hematologist John Snowden, BSc (Hons), MBChB, MD, FRCP, FRCPath, and neurologist Basil Sharrack, MD, PhD, FRCP, discussed their results